Abgenix (ABGX) 8-K Financial statements and exhibits

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report:

February 24, 2004

(Date of earliest event reported)

ABGENIX, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-24207	94-3248826
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employee Identification No.)
	6701 Kaiser Drive Fremont, California 94555
	(Address of principal executive offices) (Zip Code)
	(510)- 284-6500
	Registrant’s telephone, including area code:
	(Former name and former address, if changed since last report)

Item 7.Financial Statements and Exhibits.

(c)Exhibits.

Exhibit No.	Description
99.1	Press Release of Abgenix, Inc. dated February 24, 2004

Item 12.Disclosure of Results of Operations and Financial Condition.

On February 24, 2004, Abgenix, Inc. issued a press release to report the company’s financial results for the fourth quarter and year ended December 31, 2003. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ABGENIX, INC.
Dated:  February 24, 2004	By:	/s/ Raymond Withy
		Raymond M. Withy, Ph.D. Chief Executive Officer

2

EXHIBIT INDEX

EXHIBIT NO.	DESCRIPTION
99.1	Press Release of Abgenix, Inc. dated February 24, 2004

3